Hydralazine Hydrochloride Tablet
Product Images NDC 72162-1521

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydralazine Hydrochloride (NDC 72162-1521). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chem Structure (Hydralazine Hydrochloride Tablet 089097 088467 088 1)

Chem Structure (Hydralazine Hydrochloride Tablet 089097 088467 088 1)
Chemical structure of Hydralazine Hydrochloride showing a bicyclic ring system with hydrazine and hydrochloride groups attached.*
FDA Label Image

Label (Lbl721621521)

Label (Lbl721621521)
Label for Hydralazine Hydrochloride Tablets USP, 25 mg, oral tablets, packaged in a quantity of 1000 tablets. The label indicates the product is relabeled by Bryant Ranch Prepack, Inc. and manufactured by Teva Czech Industries, s.r.o. Storage recommendations and a QR code for full prescribing information are also present.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.